Evidence map›Paper›PMID 38029403›Full record

ReviewAging and disease2023

ARID1a Gene as a Potential Early Marker to Tackle Endometriosis-Associated Ovarian Cancer.

Pawel Kordowitzki, Sylvia Mechsner, Jalid Sehouli

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Aging and disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 68% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 0 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Pawel KordowitzkiDepartment of Preclinical and Basic Sciences, Nicolaus Copernicus University, Torun, Poland.
Sylvia MechsnerDepartment of Gynecology including Center of Oncological Surgery (CVK) and Department of Gynecology (CBF), European Competence Center for Ovarian Cancer, Charite, Berlin, Germany.
Jalid SehouliDepartment of Gynecology including Center of Oncological Surgery (CVK) and Department of Gynecology (CBF), European Competence Center for Ovarian Cancer, Charite, Berlin, Germany.
Nicolaus Copernicus University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The worries of women with endometriosis - a chronic gynecological disease affecting approximately 10% of women of childbearing age - about the increased risk of ovarian cancer are present worldwide. Endometriosis is a common, often painful, but benign gynecological disease that affects women. However, the pathogenesis remains elusive but is certainly multifactorial. Interestingly, endometriosis shares similarities with cancer. Therefore, women suffering from endometriosis fear an increased risk of ovarian cancer. In addition, these patients suffer from anxiety and depression. Previous studies have provided evidence that epithelial mutations in endometriosis or in the endometrium include certain inactivating mutations responsible for ovarian cancer, such as in the ARID1A gene.

Indexed as

DNA-Binding ProteinsEndometriosisOvarian NeoplasmsTranscription FactorsBiomarkers, TumorFemaleHumansMutationARID1A protein, humanBiomarkers, TumorDNA-Binding ProteinsTranscription Factors

Identifiers

PMID38029403
PMCPMC11567265
OpenAlexW4388760951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.